ask="2.00"
ask_size="1600"
average_daily_volume="294882"
bid="1.95"
bid_size="100"
book_value="0.88"
change="+0.00"
change_from_200_day_moving_average="-1.41"
change_from_50_day_moving_average="-0.18"
change_from_52_week_high="-4.98"
change_From_52_week_low="0.18"
change_in_percent="+0.00%"
close="1.95"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.30"
ebitda="-36.93M"
eps_estimate_current_year="-1.35"
eps_estimate_next_quarter="-0.28"
eps_estimate_next_year="-1.04"
ex_dividend_date="N/A"
float_shares="28175000"
high="2.00"
high_52_weeks="6.93"
last_trade_date="3/1/2017"
last_trade_price="1.95"
last_trade_size="5061"
last_trade_time="4:00pm"
low="1.95"
low_52_weeks="1.77"
market_capitalization="59.70M"
moving_average_200_day="3.36"
moving_average_50_day="2.13"
name="TrovaGene
Inc."
notes="N/A"
one_year_target_price="6.23"
open="1.95"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-41.93%"
percent_change_from_50_day_moving_average="-8.27%"
percent_change_from_52_week_high="-71.86%"
percent_change_from_52_week_low="+9.86%"
previous_close="1.95"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.23"
price_per_sales="152.23"
revenue="392168.00"
shares_outstanding="30615000"
short_ratio="10.94"
stock_exchange="NCM"
symbol="TROV"
volume="146689"
weeks_range_52="1.77 - 6.93"
